Par Pharmaceutical, Inc. et al v. American Regent, Inc.
Plaintiff: Par Sterile Products, LLC, Par Pharmaceutical, Inc. and Endo Par Innovation Company, LLC
Defendant: American Regent, Inc.
Case Number: 1:2019cv01490
Filed: August 9, 2019
Court: US District Court for the District of Delaware
Presiding Judge: Colm F Connolly
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35 U.S.C. § 271
Jury Demanded By: None
Docket Report

This docket was last retrieved on October 1, 2019. A more recent docket listing may be available from PACER.

Date Filed Document Text
October 1, 2019 Opinion or Order Filing 23 ORDER Setting Teleconference: Plaintiffs' counsel to initiate the call. A Telephone Conference is set for 10/11/2019 at 11:30 AM Eastern Time with Judge Mary Pat Thynge to discuss ADR. Signed by Judge Mary Pat Thynge on 10/1/19. Associated Cases: 1:18-cv-02032-CFC, 1:19-cv-00712-CFC, 1:19-cv-01490-CFC(cak)
September 27, 2019 Opinion or Order Filing 22 SO ORDERED, re (31 in 1:19-cv-00712-CFC, 44 in 1:18-cv-02032-CFC, 20 in 1:19-cv-01490-CFC) STIPULATION and ORDER OF Consolidation. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 18-2032-CFC ONLY. Signed by Judge Colm F. Connolly on 9/26/2019. Associated Cases: 1:18-cv-02032-CFC, 1:19-cv-00712-CFC, 1:19-cv-01490-CFC(nmf)
September 27, 2019 Opinion or Order Filing 21 PROTECTIVE ORDER Signed by Judge Colm F. Connolly on 9/26/2019. Associated Cases: 1:18-cv-02032-CFC, 1:19-cv-00712-CFC, 1:19-cv-01490-CFC(nmf)
September 27, 2019 Case associated with lead case: Create association to 1:18-cv-02032-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 1:18-cv-02032-CFC ONLY. (nmf)
September 25, 2019 Filing 20 STIPULATION and [Proposed] Order for Consolidation by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Attachments: #1 Exhibit A, #2 Exhibit B)(Farnan, Brian)
September 23, 2019 Filing 19 NOTICE of Appearance of Joseph J. Gribbin by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC (Farnan, Brian)
September 20, 2019 Filing 18 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Endo International PLC for Par Pharmaceutical, Inc.; Corporate Parent Par Pharmaceutical, Inc. for Endo Par Innovation Company, LLC; Other Affiliate Par Pharmaceutical, Inc. for Par Sterile Products, LLC filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Farnan, Brian)
September 17, 2019 Filing 17 ANSWER to #10 Answer to Complaint,, Counterclaim, by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC.(Farnan, Brian)
September 16, 2019 Filing 16 REDACTED VERSION of #10 Answer to Complaint,, Counterclaim, by American Regent, Inc.. (Stamoulis, Stamatios)
September 16, 2019 Filing 15 NOTICE OF SERVICE of (i) Plaintiffs' Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1)(A) and (ii) Plaintiffs' Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC.(Farnan, Brian)
September 16, 2019 Pro Hac Vice Attorney Robert D. Rhoad for Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd)
September 13, 2019 Filing 14 NOTICE OF SERVICE of Defendant American Regent Inc.s Rule 26(a) Initial Disclosures and Defendants Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by American Regent, Inc..(Stamoulis, Stamatios)
September 6, 2019 Pro Hac Vice Attorney Uma N. Everett for American Regent, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd)
September 6, 2019 Opinion or Order SO ORDERED, re #13 MOTION for Pro Hac Vice Appearance of Attorney Sharon K. Gagliardi and Robert D. Rhoad filed by Endo Par Innovation Company, LLC, Par Sterile Products, LLC, Par Pharmaceutical, Inc. Signed by Judge Colm F. Connolly on 9/6/2019. (fms)
September 6, 2019 Pro Hac Vice Attorneys Sharon K. Gagliardi for Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., and Par Sterile Products, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd)
September 5, 2019 Filing 13 MOTION for Pro Hac Vice Appearance of Attorney Sharon K. Gagliardi and Robert D. Rhoad - filed by Endo Par Innovation Company, LLC, Par Pharmaceutical, Inc., Par Sterile Products, LLC. (Farnan, Brian)
September 4, 2019 Filing 12 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,375,478 B1 ;9,687,526 B2 ;9,744,209 B2 ;9,750,785 B2 ;9,744,239 B2 . (Stamoulis, Stamatios)
September 4, 2019 Filing 11 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Daiichi Sankyo, Inc., Corporate Parent Daiichi Sankyo U.S. Holdings, Inc., Corporate Parent Baiichi Sankyo Company, Limited for American Regent, Inc. filed by American Regent, Inc.. (Stamoulis, Stamatios)
September 4, 2019 Pro Hac Vice Attorney Dennies Varughese for American Regent, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d), Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (sam)
September 3, 2019 NOTICE TO COUNSEL Stamatios Stamoulis, Esq.: The Patent/Trademark Report and Rule 7.1 Disclosure Statement filed as attachments to the Answer and Counterclaim at D.I. #10 should be docketed separately using the appropriate docket codes found under OTHER FILINGS, OTHER DOCUMENTS. (fms)
August 30, 2019 Filing 10 [SEALED] ANSWER to #1 Complaint, , COUNTERCLAIM against All Plaintiffs by American Regent, Inc.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Patent/Trademark Report, #4 Exhibit Rule 7.1 Statement)(Stamoulis, Stamatios)
August 30, 2019 Pro Hac Vice Attorney Charles T. Wysocki for American Regent, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd)
August 28, 2019 Opinion or Order SO ORDERED, re #9 MOTION for Pro Hac Vice Appearance of Attorney Uma N. Everett filed by American Regent, Inc. Signed by Judge Colm F. Connolly on 8/28/2019. (fms)
August 28, 2019 Minute Entry for proceedings held before Judge Colm F. Connolly - Scheduling Conference held on 8/28/2019. (Court Reporter S. Ingraham, Hawkins Reporting.) Counsel to submit the final revised scheduling order to the Court. Associated Cases: 1:18-cv-02032-CFC, 1:19-cv-00712-CFC, 1:19-cv-01490-CFC(nmf)
August 27, 2019 Filing 9 MOTION for Pro Hac Vice Appearance of Attorney Uma N. Everett - filed by American Regent, Inc.. (Stamoulis, Stamatios)
August 27, 2019 Opinion or Order ORAL ORDER re (6 in 1:19-cv-01490-CFC, 39 in 1:18-cv-02032-CFC, 27 in 1:19-cv-00712-CFC) Letter. A Telephone Scheduling Conference is set for 8/28/2019 at 11:00 AM before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 8/27/2019. Associated Cases: 1:19-cv-01490-CFC, 1:18-cv-02032-CFC, 1:19-cv-00712-CFC(fms)
August 27, 2019 Opinion or Order SO ORDERED, re #8 MOTION for Pro Hac Vice Appearance of Attorney Dennies Varguhese and Charles Wysocki filed by American Regent, Inc. Signed by Judge Colm F. Connolly on 8/27/2019. (fms)
August 26, 2019 Filing 8 MOTION for Pro Hac Vice Appearance of Attorney Dennies Varguhese and Charles Wysocki - filed by American Regent, Inc.. (Stamoulis, Stamatios)
August 26, 2019 Filing 7 NOTICE of Appearance by Stamatios Stamoulis on behalf of American Regent, Inc. (Stamoulis, Stamatios)
August 26, 2019 Filing 6 Letter to The Honorable Colm F. Connolly from Brian E. Farnan regarding August 28, 2019 Scheduling Conference. (Farnan, Brian)
August 22, 2019 Filing 5 SUMMONS Returned Executed by Par Sterile Products, LLC, Par Pharmaceutical, Inc., Endo Par Innovation Company, LLC. American Regent, Inc. served on 8/15/2019, answer due 9/5/2019. (Farnan, Brian)
August 14, 2019 Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (nmg)
August 9, 2019 Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,375,478 B1; US 9,687,526 B2; US 9,744,209 B2; US 9,750,785 B2. (kmd)
August 9, 2019 Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 6/28/2019. Date of Expiration of Patent: 1/30/2035.Thirty Month Stay Deadline: 12/28/2021. (kmd)
August 9, 2019 Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (kmd)
August 9, 2019 Filing 1 COMPLAINT filed against American Regent, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2705391.) - filed by Par Sterile Products, LLC, Par Pharmaceutical, Inc., Endo Par Innovation Company, LLC. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Civil Cover Sheet)(kmd)
August 9, 2019 Summons Issued with Magistrate Consent Notice attached as to American Regent, Inc. on 8/9/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (kmd)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Par Pharmaceutical, Inc. et al v. American Regent, Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: American Regent, Inc.
Represented By: Charles T. Wysocki
Represented By: Dennies Varughese
Represented By: Stamatios Stamoulis
Represented By: Uma N. Everett
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Par Sterile Products, LLC
Represented By: Michael J. Farnan
Represented By: Brian E. Farnan
Represented By: Sharon K. Gagliardi
Represented By: Robert D. Rhoad
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Par Pharmaceutical, Inc.
Represented By: Michael J. Farnan
Represented By: Brian E. Farnan
Represented By: Sharon K. Gagliardi
Represented By: Robert D. Rhoad
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Endo Par Innovation Company, LLC
Represented By: Michael J. Farnan
Represented By: Brian E. Farnan
Represented By: Sharon K. Gagliardi
Represented By: Robert D. Rhoad
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?